International Flavors & Fragrances Inc.

🥛 IFF launches YO-MIX PRIME cultures to help yogurt makers cut added sugar while maintaining texture and taste.

🧬 The technology slows post-acidification, stabilizing pH levels and preventing excessive sourness in reduced-sugar formulations over shelf life.

📉 Manufacturers can achieve cleaner labels by relying on fermentation behavior rather than high-intensity sweeteners or extra stabilizers.

🏭 The cultures offer operational robustness, tolerating temperature variations to reduce off-spec batches and product waste.

🌍 YO-MIX PRIME is compatible with various milk sources and fat levels, supporting global market localization strategies.

💰 IFF's strategic focus on high-margin specialties aligns with a $4.3 billion divestiture of its Food Ingredients unit to CVC Capital Partners.

📈 The product targets the growing demand for clean-label dairy products, particularly in children's and family yogurt segments.

🔬 Strains are optimized to metabolize lactose effectively, generating a creamy sensory profile associated with indulgence.

🚀 IFF aims to command premium pricing by offering sophisticated culture solutions that intersect texture, flavor, and nutrition.

📈 IFF shares jumped 7.2% following Benchmark's coverage initiation and confirmation of a US$4.3 billion divestiture of its Food Ingredients segment.

🤝 The planned sale to CVC Capital Partners is targeted for closing by late Q2 2027, marking a major strategic pivot for the company.

🎯 Benchmark views the deal as a catalyst to refocus operations on Taste, Scent, and Health & Biosciences while aiding deleveraging.

💰 Analysts project IFF revenue of US$11.4 billion and earnings of US$784.4 million by 2028, requiring a turnaround from current losses.

📉 Recent years have seen revenue pressure and mixed balance sheet signals that investors must weigh against the restructuring benefits.

💼 Substantial recent insider purchases are noted as a positive signal supporting the bullish investment narrative.

⚠️ Benchmark highlights financial strength concerns and potential financial distress risk as the primary near-term risks to the strategy.

📊 Benchmark's fair value estimate of US$90.71 suggests 16% upside, though other models indicate potential undervaluation up to 62%.

📈 International Flavors & Fragrances (IFF) is a $19 billion global company developing bioscience-based solutions for flavors, fragrances, and ingredients.

💼 IFF recently divested its Food Ingredients business to CVC Capital Partners for a $4.3 billion valuation, retaining a $200 million minority stake.

📉 The divestiture is expected to generate approximately $3.8 billion in net cash proceeds for debt reduction and share repurchases.

👔 Board member Paul Fribourg purchased 273,500 shares of IFF for $20.3 million shortly after the divestiture announcement.

📊 IFF's first quarter results beat expectations with revenue of $2.74 billion and non-GAAP EPS of $1.25 per share.

🔍 Barclays analyst Lauren Lieberman rates IFF as a Buy with a $90 price target, implying 23% upside potential.

🏆 Wall Street consensus gives IFF a Strong Buy rating based on 11 reviews, with an average price target of $91.78.

🏠 Radian is a mortgage insurance specialist that recently acquired specialty insurer Inigo for $1.67 billion to diversify its business.

📈 Radian's first quarter revenues reached $466 million, representing a 58% increase from the same period in 2025.

💰 CEO-elect Michael Weinbach purchased 170,000 shares of Radian for nearly $5.77 million in early June transactions.

📉 Radian declared a quarterly dividend of 25.5 cents per share, which annualizes to a forward yield of 3%.

🔍 RBC analyst Rowland Mayor rates Radian as Outperform with a $47 price target, suggesting 39% upside potential.

🏆 The Wall Street consensus for Radian is a Moderate Buy based on six recent reviews, with an average price target of $43.50.

🏢 International Flavors & Fragrances (IFF) agreed to sell its Food Ingredients business unit to CVC Capital Partners affiliates.

💰 The deal values the divested unit at approximately $4.3 billion, with IFF expecting roughly $3.8 billion in net cash proceeds.

🤝 IFF will retain a minority stake of about 10% and a board seat in the newly carved-out separate company.

📅 The transaction was publicly announced on May 29, 2026, following an agreement reached on May 28, 2026.

📊 The Food Ingredients division generated nearly $3.1 billion in sales and about $430 million of EBITDA in 2025.

🎯 This divestiture marks a major step in IFF's portfolio transformation to focus on Taste, Scent, and Health & Biosciences businesses.

💸 Proceeds from the sale will primarily be used for debt reduction, targeted share buybacks, and reinvestment in core operations.

⚠️ Management warns that the divestiture is expected to be dilutive to adjusted EPS in the first 12 months after closing.

📈 Despite short-term dilution, IFF is reiterating its 2026 sales and EBITDA guidance for mid-single-digit revenue growth.

🌍 CVC views the Food Ingredients arm as well-positioned in a resilient sector driven by rising global food consumption.

⏳ The deal is expected to close by the end of the second quarter of 2027, subject to regulatory clearances.

📉 Analyst Spark rates IFF stock as Neutral due to improving fundamentals but notes a relatively high P/E ratio.

🔄 IFF has been actively reshaping its portfolio in recent years by divesting 13 non-core businesses for nearly $10 billion in gross proceeds.

🧬 The company's core activities span technology-enabled taste solutions, scent, and health and biosciences offerings like probiotics and enzymes.

🤝 IFF has signed a deal with CVC Capital Partners to sell its Food Ingredients business for $4.3 billion.

💰 The transaction will generate approximately $3.8 billion in net cash proceeds for International Flavors & Fragrances Inc.

📅 The deal is expected to close by the end of the second quarter of 2027, subject to closing conditions.

🔄 IFF has divested 13 non-core businesses previously, generating about $10 billion in gross proceeds to improve its balance sheet.

🎯 The sale aligns with a strategy to focus on three core innovation-driven businesses targeting health, well-being, and sustainability.

📈 Management projects long-term revenue growth in the mid-single digits and adjusted EBITDA growth in the high-single digits.

💵 Proceeds will be allocated toward debt reduction, share repurchases, and reinvestment in high-return core opportunities.

📊 IFF's shares have gained 2.9% year-to-date compared to the industry average of 3.3%.

🏢 International Flavors & Fragrances (IFF) agreed to sell its food ingredients business to funds advised by CVC Capital Partners for approximately $4.3 billion.

🧪 The divested unit specialized in texturants, emulsifiers, plant-based solutions, and other specialty ingredients for multinational food and beverage customers.

💰 In 2025, the Food Ingredients business generated nearly $3.1 billion in sales and approximately $430 million in earnings before taxes.

🤝 IFF will retain an approximate 10% minority equity interest in the business, valued at around $200 million.

🔄 This stake allows for continued collaboration between IFF and the newly owned Food Ingredients unit under CVC's management.

🎯 The transaction is part of IFF's portfolio transformation to strengthen its focus on innovation-driven businesses: Taste, Scent, and Health & Biosciences.

📉 Over recent years, IFF has simplified its operations by divesting 13 non-core businesses prior to this major sale.

🌍 CVC Capital Partners is a global private markets manager with offices in EMEA, the Americas, and Asia managing approximately €209 billion in assets.

🏭 Funds managed by CVC are invested in over 150 companies worldwide with combined annual sales exceeding €240 billion.

👤 The article includes biographical details about Dave Fusaro, editor-in-chief of Food Processing magazine since 2003.

📰 Food Processing magazine is described as the only media brand covering the entire food and beverage industry across all categories and job functions.

📅 The sale was announced last week by IFF, marking a significant strategic shift for the company.

🍦 International Flavors & Fragrances (IFF) is divesting its Food Ingredients segment, a unit accounting for 30% of sales and 20% of EBITDA.

💰 The total sale price for this business is set at $4.3 billion.

📉 Despite the deal being framed as strategic, the acquired multiple of 10x EBITDA is significantly lower than IFF's typical valuation.

⚠️ Analysts note that the transaction will be financially dilutive due to the low exit multiple compared to IFF's post-deal implied valuation.

📊 The company expects near-term EPS dilution resulting from the sale, though this may be partially offset by debt reduction and cost cuts.

📈 Growth guidance for International Flavors & Fragrances remains modest following the divestiture.

⚠️ Long-term stock performance has been disappointing despite recent corporate actions like this major sale.

🏢 The Food Ingredients business represents a substantial portion of the company's revenue, highlighting the scale of the restructuring.

💡 Management emphasizes that the move is aimed at focusing core operations and reducing leverage.

📝 This article is written by a member of the Value In Corporate Events group and includes standard Seeking Alpha disclosures.

📈 IFF has agreed to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion in enterprise value.

💰 The deal values the divested unit at a 10x EBITDA multiple, with IFF retaining a 10% minority equity stake worth roughly $200 million.

🔄 This transaction is part of a broader portfolio simplification strategy where IFF has previously divested 13 non-core businesses for nearly $10 billion.

🎯 The sale allows IFF to focus exclusively on its three core innovation-driven segments: Taste, Scent, and Health & Biosciences.

💵 IFF expects to receive net cash proceeds of approximately $3.8 billion after accounting for equity rollover, adjustments, and transaction costs.

📉 Proceeds will be prioritized for debt reduction, targeted share repurchases, and reinvestment in high-return growth opportunities within the core portfolio.

⚠️ The company expects the deal to be dilutive to adjusted EPS in the first 12 months following closing before capital deployment benefits materialize.

📅 The transaction is expected to close by the end of the second quarter of 2027, subject to regulatory approvals and customary conditions.

🤝 IFF will hold a board seat in the new company as part of its retained minority equity interest in the Food Ingredients business.

📊 In 2025, the divested Food Ingredients business generated nearly $3.1 billion in annual sales and approximately $430 million of EBITDA.

🚀 IFF reiterates its full-year 2026 guidance with sales expected between $10.5 billion and $10.8 billion.

💹 For 2026, adjusted operating EBITDA is projected to range from $2.05 billion to $2.15 billion.

📈 The company expects comparable currency neutral sales growth of 1% to 4% for the full year 2026.

📈 Adjusted operating EBITDA growth is anticipated to be between 3% and 8% on a comparable currency neutral basis.

🏦 J.P. Morgan Securities LLC and BofA Securities are serving as financial advisors, while Skadden Arps serves as legal advisor.

📉 IFF shares dropped $1.69 (2.1%) to close at $79.36 despite the positive operational announcement.

🏭 IFF officially opened a new 650-square-meter Vanilla Innovation Center in Toamasina, Madagascar.

🌐 The facility is strategically located near major seaports and vanilla growing regions to support origin-level innovation.

⚗️ The center integrates multiple capabilities including lab analysis, extraction, scent creation, and application development.

🧬 It enables IFF to follow the vanilla journey from field extraction through advanced lab analysis to final flavor creation.

📊 The site allows for better understanding of natural variability and translation of on-ground insights into tailored solutions.

🤝 Proximity to crops facilitates closer collaboration with farmer networks, improved traceability, and ethical sourcing.

🌱 The facility strengthens sustainability and resilience by enabling a faster response to climate-related changes in vanilla production.

🔬 Dr. Adam Janczuk stated the center connects science, creativity, and sustainability while safeguarding quality across the supply chain.

📈 IFF reported Q1 CY2026 revenue of $2.74 billion, which was 3.6% lower year-on-year but represented a 3.9% beat versus analyst estimates.

💰 Non-GAAP profit came in at $1.25 per share, significantly exceeding the $1.07 analysts had expected (a 16.5% beat).

📉 Full-year revenue guidance of $10.65 billion was reiterated but sits 0.6% below current analyst consensus estimates.

🏆 Adjusted EBITDA for the quarter reached $568 million, marking a 20.7% margin and beating expectations by 9.9%.

📊 The company's operating margin improved dramatically to 10%, recovering from a -31.8% loss in the same period last year.

🌱 Organic revenue increased by 3% year-on-year, driven by broad-based volume growth across all business units.

🩺 The Health & Biosciences segment led performance with mid-single-digit sales growth fueled by demand in animal nutrition and food biosciences.

✨ The Taste segment delivered an 18% increase in profitability compared to the prior year due to volume gains, pricing discipline, and efficiency efforts.

💼 IFF completed the sale of its commodity soy crush business and is progressing with a broader divestiture of the Food Ingredients portfolio.

🌸 While Fine Fragrance grew, the company faces pressure in commodity Fragrance Ingredients from competition in India and China.

💧 Scent segment commodities are being de-emphasized, with the company focusing on higher-growth areas like Health & Biosciences.

💰 Free cash flow saw a significant year-over-year increase attributed to operational improvements and working capital discipline.

📈 Management expects logistics, energy, and raw material inflation to continue but plans to offset it through modest initial price increases.

🔄 Proceeds from the Food Ingredients divestiture will be used to maintain leverage targets, fund organic investments, and pursue acquisitions.

⚠️ Executive leadership acknowledged ongoing risks related to geopolitical events and input cost inflation while reaffirming confidence in execution.

🔬 The company is investing in innovation, supply chain capabilities, and customer partnerships to support future growth trajectories.

📊 IFF reported adjusted earnings of $1.25 per share in Q1 2026, beating the consensus estimate of $1.08 by 15.7%.

💰 Including one-time items, total earnings were 66 cents per share compared to a loss of $3.98 in the same quarter last year.

📉 Reported net sales declined 3.6% to $2.741 billion but exceeded analyst estimates and showed 3% growth on a currency-neutral basis.

🔧 Gross margin improved to 37.1%, driven by a 5% year-over-year reduction in cost of goods sold.

🚀 Adjusted operating EBITDA rose 11.6% to $568 million, with margins expanding from 17.9% to 20.7%.

🧪 All four business segments reported comparable currency-neutral sales growth, totaling 3% on a neutral basis.

🍫 The Food Ingredients segment led top-line growth at 7.7% year-over-year, reaching $839 million in net sales.

💊 Health & Bioscience revenue grew 10.4% to $595 million, driven by Animal Nutrition and Food Biosciences.

👃 Scent segment sales increased 6% to $651 million, though currency-neutral growth was modest at 1%.

💵 Operating cash flow jumped significantly to $257 million, while free cash flow reached $92 million after capex.

🏦 Net debt levels remained steady at $4.74 billion with a leverage ratio of 2.5x credit-adjusted EBITDA.

🔮 IFF reaffirmed its full-year 2026 guidance, expecting sales between $10.5 and $10.8 billion.

💼 Management is actively selling portions of the Food Ingredients business to maximize shareholder value.

📉 IFF shares have underperformed the broader industry by 6% over the past year despite strong operational results.

⚖️ Analyst Zacks Investment Research maintains a "Hold" (Rank #3) rating on International Flavors & Fragrances.

📅 IFF held its First Quarter 2026 earnings call on May 6, 2026, with CEO Erik Fyrwald and CFO Michael DeVeau participating.

🏢 The company reported revenue of over $2.7 billion for Q1 2026, driven by volume growth across all business segments.

📈 Sales growth reached 3% in the quarter, led by mid-single-digit growth in the Health & Biosciences segment and low single-digit growth in Taste, Food Ingredients, and Scent.

💰 Strong free cash flow was generated compared to last year, attributed to a focus on cash and working capital management.

📉 Portfolio simplification efforts have enabled IFF to reinvest in core high-growth businesses while meeting deleveraging targets.

💸 The company completed the $110 million divestiture of its commodity soy crush, concentrates, and lecithin business to Bunge in March 2026.

🔄 The sale process for the remaining Food Ingredients business is ongoing with strong interest from potential buyers, though no further updates were provided today.

🌎 IFF expanded regional production and innovation capabilities in Latin America to support the growth of its Health & Biosciences segment.

🧬 New facilities include the startup of the Areito enzyme production site in Argentina and a household care laboratory at the Innovation Center in Brazil.

🏭 These new capacities aim to improve speed, reliability, and provide locally relevant solutions for brewing, animal nutrition, biofuels, and home care markets.

⚠️ CEO Erik Fyrwald noted that global uncertainty, including the ongoing Middle East conflict, will persist throughout 2026.

📊 Despite macroeconomic challenges, management reaffirmed its full-year 2026 financial guidance ranges based on disciplined execution.

🛡️ IFF positions itself to navigate volatility through its diversified portfolio and the essential nature of its products and services.

🤝 Management is committed to working with customers to offset inflation while advancing commercial and innovation pipelines.

🎯 The leadership team remains focused on strategic goals laid out two years ago, emphasizing execution, productivity, and cash flow.

📊 CFO Michael DeVeau was set to provide further details on segment performance and consolidated results after the CEO's remarks.

📈 IFF reported adjusted earnings of $1.25 per share in Q1 2026, up 4.2% year-over-year and beating the Zacks Consensus Estimate of $1.08 by 15.7%.

💰 Including one-time items, earnings rose from a prior-year loss of $3.98 to 66 cents per share for the quarter.

📉 Net sales totaled $2.741 billion, down 3.6% year-over-year but remaining 3.4% above the analyst consensus mark.

💧 On a comparable currency-neutral basis, sales grew 3% driven by volume gains across all four business segments.

📉 Cost of goods sold decreased 5% to $1.7 billion, while gross profit dipped 1.6% to approximately $1 billion.

📊 Gross margin expanded to 37.1%, compared with 36.4% in the same period last year.

🧬 Research and development expenses fell 7.4% to $427 million, while selling and administrative expenses rose slightly to $166 million.

💸 Adjusted operating EBITDA reached $568 million, representing an 11.6% increase from the prior-year quarter.

📈 Currency-neutral adjusted operating EBITDA improved 8% year-over-year on the back of volume growth and productivity gains.

🧂 The Taste segment saw net sales rise 5.6% to $656 million, though adjusted operating EBITDA dropped 29% to $153 million.

🍫 Food Ingredients sales climbed 7.7% to $839 million, with currency-neutral growth of 3% driven by volume increases.

💊 Health & Bioscience generated $595 million in sales, up 10% year-over-year, led by growth in Animal Nutrition and Food Biosciences.

🌸 The Scent segment reported $651 million in sales, a 6% year-over-year increase with mixed performance across sub-sectors.

💵 Cash flow from operations strengthened significantly to $257 million, compared to just $1.27 million in the prior-year quarter.

🏦 IFF ended the quarter with $562 million in cash and equivalents, while maintaining long-term debt at $4.74 billion for a net debt-to-EBITDA ratio of 2.5x.

✅ Management reaffirmed full-year 2026 guidance despite an unsettled operating environment, expecting sales between $10.5 billion and $10.8 billion.

🔄 The company updated its full-year view following the March 2, 2026 divestiture of its Soy Crush, Concentrates and Lecithin business.

🚀 IFF is currently progressing a disciplined sale process for its Food Ingredients business to maximize shareholder value.

⚠️ IFF shares have lost 6% over the past year, lagging the industry's growth rate of 4.6%.

📉 Linde plc and PPG Industries also reported strong Q1 earnings results with revenue beats or meeting estimates.

🎨 Sherwin-Williams reported first-quarter earnings of $2.15 per share, up 7.5% year-over-year from the prior period.

📈 International Flavors (IFF) reported Q1 earnings of $1.25 per share, beating the Zacks Consensus Estimate of $1.08 per share.

💰 This represents a 16.01% positive earnings surprise compared to last quarter's negative surprise of -5.88%.

📊 The company generated $2.74 billion in revenue for the quarter, which exceeded consensus estimates by 3.44%.

🏆 IFF has surpassed consensus EPS and revenue estimates three out of the last four quarters.

📉 Stock performance context shows IFF shares added about 4% YTD versus the S&P 500's gain of 5.2%.

⚖️ Current estimate revisions are mixed, resulting in a Zacks Rank #3 (Hold) for the stock.

💡 Future stock movement depends on management commentary and potential changes in earnings estimate trends.

🔮 The current consensus EPS expectation is $1.15 for the next quarter on $2.74 billion in revenue.

🏭 IFF belongs to the Zacks Chemical - Specialty industry, which is ranked in the bottom 27% of all industries.

📅 Peer company Neo Performance Materials (NOPMF) is scheduled to report earnings on May 12.

🚀 NOPMF is expected to show a significant 137.5% year-over-year increase in earnings per share of $0.19.

💹 NOPMF's revenue is projected at $130.33 million, representing a 7.2% increase from the prior year.

📊 IFF reported Q1 CY2026 revenue of $2.74 billion, which beat analyst estimates of $2.64 billion despite a 3.6% year-on-year decline.

💰 Non-GAAP earnings per share (EPS) came in at $0.83, significantly missing the analyst consensus of $1.07 by 22.6%.

📉 Full-year revenue guidance was lowered to $10.65 billion, sitting 0.6% below the midpoint of Wall Street estimates.

💵 Adjusted EBITDA reached $568 million, a 9.9% beat over estimates of $516.6 million with a margin of 20.7%.

🔄 Operating margin improved to 10%, recovering from a loss of -31.8% in the same quarter last year.

💧 Free cash flow turned positive at $92 million, reversing the -$52 million burn rate seen in the prior-year quarter.

🌿 Organic revenue grew by 3% year-on-year, beating analyst expectations despite overall top-line decline.

📈 The stock price jumped 4.8% to close at $74.19 immediately after earnings results were released.

🏢 IFF generates scents for perfumes and flavors for food and beverages, serving the personal care and pharmaceutical sectors.

📉 Long-term sales have been weak with annual declines averaging 4.1% over the last three years.

🔍 Analysts project flat revenue growth over the next 12 months as the company seeks new product traction.

⚠️ Management faces challenges finding incremental growth due to high market penetration in its existing brands.

💸 The company has struggled with cash profitability relative to peers, averaging a free cash flow margin of only 4.4%.

📉 Margins contracted by 1.3 percentage points over the last year, signaling potential operational pressure.

🎯 Future growth strategies likely involve pricing optimization or expansion into international markets.

🔍 The mixed earnings report highlights key positives in EBITDA and organic revenue but misses in EPS and guidance.

📈 International Flavors & Fragrances (IFF) shares rose 5.4% in after-hours trading and 1% during regular trading to $70.77, adding to a 5% year-to-date gain.

💰 The company swung to a reported profit of $169 million, or 66 cents per share, reversing a loss of $1.02 billion from the same period last year.

📊 Adjusted earnings came in at 83 cents per share after stripping one-time items, though this missed analyst consensus estimates of $1.07 per share.

🧮 When excluding amortization, adjusted earnings reached $1.25 per share.

📉 Net sales declined by 4% year-over-year to $2.74 billion, which was slightly higher than the $2.64 billion analysts had expected.

🚀 IFF expects full-year sales to range between $10.5 billion and $10.8 billion, aligning closely with analyst expectations of $10.72 billion.

⚠️ Management noted that divestitures will have a roughly 5% adverse impact on overall sales growth for the current year.

📈 International Flavors & Fragrances (IFF) reported first-quarter 2026 results that exceeded Wall Street estimates for both sales and profit.

💰 The company recorded quarterly net sales of $2.74 billion, surpassing analyst consensus estimates of $2.64 billion.

💵 Adjusted earnings per share came in at $1.25, significantly higher than the projected $1.07 estimate.

🧬 Strong performance was driven by volume gains in the food ingredients segment, which saw adjusted operating EBITDA rise 12%.

👃 Conversely, the scent segment experienced a 2% decline in earnings due to high input costs despite maintained sales growth.

🌱 The company is executing a strategy to sell non-core businesses and focus on flavors, fragrances, and health ingredients.

💼 Last year, IFF completed the sale of its pharma solutions business to French firm Roquette for $2.85 billion.

📈 Shares of the New York-based company rose approximately 5% in after-hours trading following the earnings release.

🤵 CEO Erik Fyrwald highlighted delivery of volume growth across all four segments, improved profitability, and strong cash flow generation.

🔮 IFF maintained its annual sales forecast between $10.5 billion and $10.8 billion.

💸 The company also reaffirmed its annual adjusted operating core profit guidance ranging from $2.05 billion to $2.15 billion.

🛡️ Management attributed resilience in consumer spending on health and wellness to the solid demand for its products.

📈 IFF reported consolidated net sales of $2.74 billion for Q1 2026, representing a 4% decrease on a reported basis but a 3% increase on a comparable, currency-neutral basis.

💰 Adjusted operating EBITDA reached $568 million in the quarter, an 8% improvement year-over-year driven by volume growth and productivity gains.

📊 Reported earnings per share (EPS) was $0.66, while adjusted EPS excluding amortization came in at $1.25 per diluted share.

💧 Cash flows from operations increased to $257 million, while free cash flow rose significantly to $92 million compared to the prior year.

🏦 The company maintained a healthy balance sheet with a net debt to credit-adjusted EBITDA ratio of 2.5x at the end of the quarter.

🥫 Taste segment sales increased 18% on a comparable basis, contributing $153 million in adjusted operating EBITDA with a 23.3% margin.

💊 Health Biosciences delivered strong performance with 7% growth in adjusted operating EBITDA, primarily driven by volume increases across businesses.

🧴 Scent segment sales saw a slight decrease of 2% on a comparable basis due to unfavorable pricing on input costs despite volume growth.

🍲 Food Ingredients division achieved a 12% increase in adjusted operating EBITDA, supported by productivity gains and volume growth in key areas.

💼 The company reaffirmed its full-year 2026 guidance, expecting total sales between $10.5 billion and $10.8 billion.

🤝 IFF is continuing a disciplined sale process for its Food Ingredients business to maximize shareholder value while operating in an unsettled environment.

⚖️ The full-year financial outlook includes two months of results from the divested Soy Crush, Concentrates, and Lecithin businesses following a March 2 closing.

💹 Management expects foreign exchange rates to provide approximately a 1% positive impact on overall sales growth during the remainder of 2026.

⚠️ Proceeds from recent divestitures are anticipated to have an approximate 5% adverse impact on both sales and adjusted operating EBITDA for the full year.

📣 CEO Erik Fyrwald highlighted a solid operational execution and customer focus that helped deliver volume growth across all four business segments.

🗓️ A live webcast discussing these Q1 2026 financial results is scheduled to take place on May 6, 2026, at 9:00 a.m. ET.

International Flavors & Fragrances Inc. (IFF) is scheduled to report its first-quarter 2026 earnings on May 5 after the closing bell.

Analysts expect sales to reach $2.65 billion, representing a 6.7% decline from the year-ago period.

The consensus earnings estimate stands at $1.08 per share, which marks a 10% year-over-year decrease.

Zacks Investment Research maintains a Zacks Rank #3 (Hold) for IFF, though their model currently predicts an earnings beat.

IFF's Earnings ESP of +2.09% suggests positive sentiment ahead of the report based on recent performance patterns.

The company has seen volume growth across all businesses and implemented productivity improvements to reduce costs.

However, rising raw material prices along with increased labor, shipping, and cleaning expenses are expected to pressure margins.

Following segment restructuring in 2025, IFF now operates four divisions: Taste, Food Ingredients, Health & Bioscience, and Scent.

The Taste segment is projected to post $649 million in sales (3.5% growth) and $139 million in adjusted operating EBITDA.

Food Ingredient sales are estimated at $797 million with a 0.1% increase, while Health & Bioscience revenue is forecast at $558 million.

Scent segment revenue is expected to rise 3.7% to $637 million, supported by momentum in consumer and fine fragrances.

IFF shares have underperformed relative to the industry by 8.4% over the past year, contrasting with broader sector gains.

The article also highlights other Basic Materials stocks like CF Industries and Albemarle that are anticipated to beat earnings expectations.

🏭 International Flavors & Fragrances Inc. (IFF) manufactures food, beverage, health, and scent products through four main segments including Taste, Food Ingredients, Health & Biosciences, and Scent.

🏢 IFF was incorporated in 1909 and is headquartered in New York, with operations spanning the United States and internationally.

⚙️ Element Solutions Inc. operates as a specialty chemicals technology company focused on electronics assembly solutions, circuitry solutions, semiconductor materials, industrial solutions, and energy solutions.

🏙️ Element Solutions was founded in 1785, changed its name from Platform Specialty Products Corporation in January 2019, and is based in Miami Beach, Florida.

💵 As of May 1, 2026, IFF had a market capitalization of $18.1 billion compared to the Chemicals industry median of $3.6 million.

📈 Element Solutions holds a $10.5 billion market cap and ranks in the 78th percentile of all stocks as of the same date.

📉 IFF's stock is down 9.75% over the past year with trailing 12-month revenue of $10.9 billion and a negative 3.3% net profit margin.

🚀 Element Solutions' stock has surged 110.73% in the past year, with trailing 12-month revenue of $2.8 billion and a positive 5.3% net profit margin.

❄️ IFF currently does not have a price-earnings ratio, whereas Element Solutions trades at a P/E of 70.0.

💰 IFF offers a 2.3% dividend yield compared to Element Solutions' 0.7% dividend yield.

📉 IFF reported year-over-year quarterly sales growth of -6.6%, while Element Solutions saw sales growth of 41.5%.

👩‍🔬 Analysts expect adjusted earnings of $4.395 per share for IFF versus $1.772 per share for Element Solutions in the current fiscal year.

📊 Recent stock movements show IFF down 0.5% in the last five days, while Element Solutions is up 6.7%.

🏆 A+ Investor by AAII provides proprietary A-F stock grades based on value, growth, momentum, earnings estimate revisions, and other key investing factors.